A Report from the NCI Comparative Brain Tumor Consortium (CBTC) Glioma Pathology Board: A Revised Diagnostic Classification in Support of Validation of the Canine Glioma Patient as a Model for Humans.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      On September 14-15, 2015, a meeting of clinicians and investigators in the fields of veterinary and human neuro-oncology and neuropathology was convened at the National Institutes of Health campus in Bethesda, Maryland. Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients. A revised diagnostic classification of canine glioma: towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma. [Extracted from the article]
    • Abstract:
      Copyright of Veterinary Pathology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)